Ron Do, PhD, associate professor, Charles Bronfman Institute for Personalized Medicine at Mount Sinai, and Iain Forrest, MD-PhD candidate in Dr Do’s lab, discuss their hopes for their findings and how genetic data are being used in health care.
Ron Do, PhD, associate professor, Charles Bronfman Institute for Personalized Medicine at Mount Sinai, and Iain Forrest, MD-PhD candidate in Dr Do’s lab, discuss how they hope their recent study findings on penetrance of pathogenic and loss-of-function clinical variants can be used and how genetic data are being used in health care.
Transcript
How do you hope the results of your study will be used?
Do: I'll just say, for this study, we wanted to bring attention to the fact that penetrance appeared variable but generally low and penetrance wasn't necessarily concordant with pathogenicity labels. Penetrance doesn't necessarily mean the same thing as pathogenicity.
Forrest: Adding onto that, we also hope that this study will raise important discussions and dialogue about whether a new type of classification system—one based on penetrance, perhaps—to assess disease risk of variants is warranted and this could actually complement the current system based on pathogenicity, which is a categorical system.
Are we approaching any milestones in the understanding of genetic variants?
Do: We feel that this study is a good first step to understanding the disease risk, or penetrance, of genetic variants. However, more research is needed to calculate penetrance in a much larger number of samples to obtain more accurate penetrance estimates at the variant level.
Forrest: The milestone that we're hitting is that genetic data are being used increasingly inside health care. Improving the precision of our interpretations of variants with penetrance will aid in the integration of an individual's genetic data in their health care and help achieve personalized medicine, whereby an individual's unique sequence of DNA can actually shape their clinical care.
Dr Kathryn Lindley Explains the Importance of Cardio-Obstetrics in Fellowship Programs
December 5th 2023Kathryn Lindley, MD, FACC, Vanderbilt University Medical Center, talks about why it’s important to incorporate cardio-obstetrics training into cardiovascular disease fellowship programs.
Read More
In this interview with The American Journal of Managed Care®, Katie Queen, MD, addresses the complexity of obesity as a medical condition, pivoting to virtual care while ensuring that patients who lived in a rural location continued to receive adequate care, and the importance of integrating awareness of obesity and chronic disease prevention into local food culture.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Recent T1D Research Contradicts Common Assumptions About Patients
November 15th 2023Michael Fang, PhD, researcher and assistant professor in the division of Cardiovascular and Clinical Epidemiology at Johns Hopkins University, discussed recent findings in the type 1 diabetes (T1D) space that may alter the way providers address diabetes diagnoses.
Read More
Christine Pfaff on Ensuring Patient Access to Affordable Treatments
October 17th 2023To ensure patients are getting timely access to their treatments, there needs to be better collaboration between payers and providers, said Christine Pfaff, RPh, senior regional director of operations, American Oncology Network.
Read More